ArticleThe Plant cell2026
Mutual potentiation of IPA1 and OsNPR1 enhances rice immunity.
Article in The Plant cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A guardian angel: how immune factor RPS2 is activated by pathogen effector AvrRpt2.The Plant cell · 2026Article
- Teamwork makes the dream work: IPA1 and OsNPR1 work together to enhance immunity in rice.The Plant cell · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Disease resistance often comes with a penalty in growth and yield. The microRNA miR156 and its target, the transcription factor gene IDEAL PLANT ARCHITECTURE 1 (IPA1), regulate developmental processes such as tillering and panicle branching while enhancing disease resistance and abiotic stress tolerance in rice (Oryza sativa). However, how this transcription factor regulates multiple processes remains unclear. Here, we found that IPA1 physically interacts with NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES 1 (OsNPR1) in the nucleus. Under normal conditions, the OsNPR1 expression levels are low, and OsCULLIN3a (OsCUL3a), an E3 ligase responsible for OsNPR1 degradation, keeps the abundance of monomeric OsNPR1 low in the nucleus and prevents IPA1 from transcriptionally regulating defense genes. When the plant is attacked by pathogens, OsNPR1 oligomers dissociate into monomers, which translocate into the nucleus and physically interact with IPA1, facilitating its binding to promoters of downstream genes, thereby activating positive defense regulators and repressing negative defense regulators. Simultaneously, IPA1 abundance increases, and IPA1 interacts with OsNPR1 and OsCUL3a, interfering with the OsCUL3a-OsNPR1 interaction, dampening the ubiquitin-mediated degradation of OsNPR1. The stabilization of OsNPR1 by IPA1 further enhances IPA1 transcriptional activity in disease resistance. Our work demonstrates that OsNPR1 facilitates IPA1 binding to the promoters of genes related to disease resistance and that IPA1 inhibits OsCUL3a-mediated degradation of OsNPR1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.